192 related articles for article (PubMed ID: 15378206)
21. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
Ariga T
Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
[TBL] [Abstract][Full Text] [Related]
22. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
23. Wiskott-Aldrich syndrome: a gene, a multifunctional protein and the beginnings of an explanation.
Kirchhausen T
Mol Med Today; 1998 Jul; 4(7):300-4. PubMed ID: 9743991
[TBL] [Abstract][Full Text] [Related]
24. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
25. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
[TBL] [Abstract][Full Text] [Related]
26. WASp in immune-system organization and function.
Thrasher AJ
Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
[TBL] [Abstract][Full Text] [Related]
27. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
28. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
29. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
30. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
Shcherbina A; Rosen FS; Remold-O'Donnell E
J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
[TBL] [Abstract][Full Text] [Related]
31. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.
Eghbali M; Sadeghi-Shabestari M; Najmi Varzaneh F; Zare Bidoki A; Rezaei N
Allergol Immunopathol (Madr); 2016; 44(5):450-4. PubMed ID: 26993433
[TBL] [Abstract][Full Text] [Related]
32. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
33. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
34. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
[TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular characteristics of Wiskott-Aldrich Syndrome in five unrelated Chinese families.
Jiang J; Zhou J; Wei M; Singh S; Nikuze L; Huang L; Li Y; Jiang J; Wei H
Scand J Immunol; 2022 Jan; 95(1):e13115. PubMed ID: 34758123
[TBL] [Abstract][Full Text] [Related]
36. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
Lemahieu V; Gastier JM; Francke U
Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
[TBL] [Abstract][Full Text] [Related]
37. Megakaryocyte-specific Profilin1-deficiency alters microtubule stability and causes a Wiskott-Aldrich syndrome-like platelet defect.
Bender M; Stritt S; Nurden P; van Eeuwijk JM; Zieger B; Kentouche K; Schulze H; Morbach H; Stegner D; Heinze KG; Dütting S; Gupta S; Witke W; Falet H; Fischer A; Hartwig JH; Nieswandt B
Nat Commun; 2014 Sep; 5():4746. PubMed ID: 25187265
[TBL] [Abstract][Full Text] [Related]
38. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
[TBL] [Abstract][Full Text] [Related]
39. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
40. Molecular biology of the Wiskott-Aldrich syndrome.
Rengan R; Ochs HD
Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
